Anthony M. Manning - 12 Jun 2024 Form 4 Insider Report for Monte Rosa Therapeutics, Inc. (GLUE)

Role
Director
Signature
/s/ Markus Warmuth, Attorney-in-Fact
Issuer symbol
GLUE
Transactions as of
12 Jun 2024
Transactions value $
$0
Form type
4
Filing time
13 Jun 2024, 16:30:09 UTC
Previous filing
26 Jul 2023
Next filing
16 Jul 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GLUE Stock Option (Right to Buy) Award $0 +22.1K $0.00 22.1K 12 Jun 2024 Common Stock 22.1K $4.16 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this option shall vest and become exercisable in full upon the earlier to occur of (i) June 12, 2025 or (ii) the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service at such time.